SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-025103
Filing Date
2023-09-05
Accepted
2023-09-05 07:15:58
Documents
14
Period of Report
2023-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20230904_8k.htm   iXBRL 8-K 29089
2 EXHIBIT 99.1 ex_566958.htm EX-99.1 25768
  Complete submission text file 0001437749-23-025103.txt   209323

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230905.xsd EX-101.SCH 3849
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230905_def.xml EX-101.DEF 13380
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230905_lab.xml EX-101.LAB 17544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230905_pre.xml EX-101.PRE 13357
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230904_8k_htm.xml XML 4245
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231234126
SIC: 2836 Biological Products, (No Diagnostic Substances)